Researchers have laid the foundation for the development of a gene therapy for the genetic heart disease arrhythmogenic cardiomyopathy (ACM). Their approach, based on replacement of the PKP2 gene, led ...

Washington University School of Medicine in St. Louis has joined the Pediatric Heart Network, a multicenter collaboration of leading hospitals and research institutions that works to improve care for ...

Australia's Murdoch Children's Research Institute is helping scientists use stem cell medicine and artificial intelligence to develop precision therapies for pediatric heart disease, the leading cause ...

Apixaban is a safe option for pediatric patients with a variety of congenital or acquired heart diseases who require chronic anticoagulation for thromboprophylaxis, the randomized SAXOPHONE study ...

Researchers from the BioTis laboratory (Inserm/University of Bordeaux, Bordeaux, France) have developed a pulmonary valve using human collagen. Such a device could revolutionize the treatment of ...

Professional cardiology societies have issued an updated guideline for the management of adult patients with congenital heart ...

Cardiovascular disease remains a leading global cause of death, and we break down its pathology, risk factors, and the critical role of lifestyle intervention.

Every year on September 29, the world observes World Heart Day, while we all talk about the ways one can protect their hearts, changes in food, and lifestyle, we often leave one very vulnerable group ...